The Drug Discovery Informatics Market Report 2021-2031: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Applying High-Performance Computing in Drug Discovery and Molecular Simulation
High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government. This technique has resulted in a number of novel drug design algorithms and new software and databases. HPC is primarily applied to the discovery and molecular modelling of medication by the Chinese Academy of Sciences, including virtual drug screening, molecular simulation dynamics and protein folding.
Growth in Demand for Novel Drug Moieties
The therapeutic moieties cannot as such be administered, hence, for patient compliance, dose precision and consistency, bioavailability, aesthetics, and reduced adverse effects, they are changed to different dosage forms. Excipients are the basic needs for these changes, so that formulators can achieve their goals. Short excipients can be described as 'the components of a formula other than the active component.' As compounds grow increasingly difficult to create, the supply, production and development of these compounds must be supplied with novel excipients. The conventional excipients have been replaced with advanced chemicals that serve multifunctional roles in current pharmaceutical dosage forms such as improved stability and bioavailability, patient acceptance and technical performance to make manufacturing easier.
What Are These Questions You Should Ask Before Buying A Market Research Report?
• How is the drug discovery informatics market evolving?
• What is driving and restraining the drug discovery informatics market?
• How will each drug discovery informatics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2031?
• How will the market shares for each drug discovery informatics submarket develop from 2021 to 2031?
• What will be the main driver for the overall market from 2021 to 2031?
• Will leading drug discovery informatics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2031 and which geographical region will lead the market in 2031?
• Who are the leading players and what are their prospects over the forecast period?
• What are the drug discovery informatics projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2031?What are the implication of drug discovery informatics projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the drug discovery informatics market?
• Where is the drug discovery informatics market heading? And how can you ensure you are at the forefront of the market?
• What can be the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path? C-suite?
You need to discover how this will impact the drug discovery informatics market today, and over the next 10 years:
• Our 519-page report provides 341 tables and 323 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• Contains in-depth analyse of global, regional and national sales and growth
• Highlights for you the key successful trends, changes and revenue projections made by your competitors
This report tells you TODAY how the drug discovery informatics market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising drug discovery informatics prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, V, L, W and U are discussed in this report.
Global Drug Discovery Informatics Market (COVID Impact Analysis) by Type
• Drug Development
• Drug Discovery
Global Drug Discovery Informatics Market (COVID Impact Analysis) by Phase
• Preclinical Testing
• Clinical Trials Phase
• Other Phase
Global Drug Discovery Informatics Market (COVID Impact Analysis) by End-User
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations
• Research Institutes
• Other End-User
Global Drug Discovery Informatics Market (COVID Impact Analysis) by Function
• Target Data
• Sequencing & Target Data Analysis
• Docking
• Molecular Modeling
• High Throughput Screening (HTS)
• Other Function
Global Drug Discovery Informatics Market (COVID Impact Analysis) by Technique
• Computer-Assisted Synthesis Design (CASD)
• Structure Representation
• Chemmetrics
• Other Technique
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 15 leading national markets:
• North America Drug Discovery Informatics Market, 2021 to 2031 Market Outlook
• U.S. Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Canada Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Mexico Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Europe Drug Discovery Informatics Market, 2021 to 2031 Market Outlook
• Germany Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Spain Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• United Kingdom Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• France Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Italy Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Rest of Europe Market Forecast & COVID Impact Analysis
• Asia Pacific Drug Discovery Informatics Market, 2021 to 2031 Market Outlook
• China Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Japan Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• India Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Australia Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• South Korea Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Rest of Asia Pacific Market Forecast & COVID Impact Analysis
• LAMEA Drug Discovery Informatics Market, 2021 to 2031 Market Outlook
• Brazil Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Turkey Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Saudi Arabia Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• South Africa Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• UAE Drug Discovery Informatics Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Rest of Latin America, Middle East and Africa
The report also includes profiles and for some of the leading companies in the Drug Discovery Informatics Market, 2021 to 2031, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Jubilant Life Sciences
• Charles River Laboratories International
• International Business Machines Corporation
• Clarivate Analytics
• Accenture
• Cognizant Technology Solutions Corporation
• Thermo Fisher Scientific
• Infosys Limited
• GVK Biosciences
• IO Informatics
• OpenEye Scientific Software Inc.
• Dassault Systèmes SE
• Collaborative Drug Discovery
• Schrödinger, Inc
• PerkinElmer Inc
Overall world revenue for Drug Discovery Informatics Market, 2021 to 2031 in terms of value the market will surpass US$xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Drug Discovery Informatics Market, 2021 to 2031 Market report helps you?
In summary, our 519-page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Drug Discovery Informatics Market, 2021 to 2031 Market, with forecasts for type, phase, function, end-user, technique each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 4 regional and 20 key national markets – See forecasts for the Drug Discovery Informatics Market, 2021 to 2031 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 15 of the major companies involved in the Drug Discovery Informatics Market, 2021 to 2031 Market.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Drug Discovery Informatics Market, 2021 to 2031 Market and leading companies. You will find data, trends and predictions.
'
1 Report Overview
1.1 Introduction to Drug Discovery Informatics Market
1.2 What are the Objectives of this Report?
1.3 What is the Scope of the Report?
1.4 Drug Discovery Informatics Market Definition
1.5 Why You Should Read This Report
1.6 What This Report Delivers
1.7 Key Questions Answered by This Analytical Report Include:
1.8 Who is This Report for?
1.9 Research Methodology
1.10 Frequently Asked Questions (FAQs)
1.11 Associated Reports
1.12 About
2 Executive Summary
3 Drug Discovery Informatics Industry Structure
3.1 Drug Discovery
3.2 Drug Development
4 Global Market Dynamics
4.1 Current Trends in the Global Market
4.2 Market Driving Factors
4.3 Market Restraining Factors
4.4 Opportunities in the Global Market
4.5 Challenges in the Global Market
4.6 Swot Analysis for Global Market
4.7 PEST Analysis for Global Market
4.8 Porter’s Five Forces
5 Global Drug Discovery Informatics Market Analysis
5.1 Global Market Outlook
5.2 Global Market Size Estimation and Forecast
5.3 Global Market Size Estimation and Forecast by Region
5.4 Global Market Size Estimation and Forecast by Type
5.5 Global Market Size Estimation and Forecast by Phase
5.6 Global Market Size Estimation and Forecast by End-User
5.7 Global Market Size Estimation and Forecast by Functions
5.8 Global Market Size Estimation and Forecast by Technique
6 North America Drug Discovery Informatics Market Analysis
6.1 North America Market Outlook
6.2 North America Market Size Estimation and Forecast
6.3 North America Market Size Estimation and Forecast by Country
6.4 North America Market Size Estimation and Forecast by Type
6.5 North America Market Size Estimation and Forecast by Phase
6.6 North America Market Size Estimation and Forecast by End-User
6.7 North America Market Size Estimation and Forecast by Functions
6.8 North America Market Size Estimation and Forecast by Technique
6.9 US Drug Discovery Informatics Market Analysis
6.10 Canada Drug Discovery Informatics Market Analysis
6.11 Mexico Drug Discovery Informatics Market Analysis
7 Europe Drug Discovery Informatics Market Analysis
7.1 Europe Market Outlook
7.2 Europe Market Size Estimation and Forecast
7.3 Europe Market Size Estimation and Forecast by Country
7.4 Europe Market Size Estimation and Forecast by Type
7.5 Europe Market Size Estimation and Forecast by Phase
7.6 Europe Market Size Estimation and Forecast by End-User
7.7 Europe Market Size Estimation and Forecast by Functions
7.8 Europe Market Size Estimation and Forecast by Technique
7.9 Germany Drug Discovery Informatics Market Analysis
7.10 UK Drug Discovery Informatics Market Analysis
7.11 France Drug Discovery Informatics Market Analysis
7.12 Italy Drug Discovery Informatics Market Analysis
7.13 Spain Drug Discovery Informatics Market Analysis
7.14 Rest of Europe Drug Discovery Informatics Market Analysis
8 Asia-Pacific Drug Discovery Informatics Market Analysis
8.1 Asia-Pacific Market Outlook
8.2 Asia-Pacific Market Size Estimation and Forecast
8.3 Asia-Pacific Market Size Estimation and Forecast by Country
8.4 Asia-Pacific Market Size Estimation and Forecast by Type
8.5 Asia-Pacific Market Size Estimation and Forecast by Phase
8.6 Asia-Pacific Market Size Estimation and Forecast by End-User
8.7 Asia-Pacific Market Size Estimation and Forecast by Functions
8.8 Asia-Pacific Market Size Estimation and Forecast by Technique
8.9 China Drug Discovery Informatics Market Analysis
8.10 India Drug Discovery Informatics Market Analysis
8.11 Japan Drug Discovery Informatics Market Analysis
8.12 South Korea Drug Discovery Informatics Market Analysis
8.13 Australia Drug Discovery Informatics Market Analysis
8.14 Rest of Asia-Pacific Drug Discovery Informatics Market Analysis
9 LAMEA Drug Discovery Informatics Market Analysis
9.1 LAMEA Market Outlook
9.2 LAMEA Market Size Estimation and Forecast
9.3 LAMEA Market Size Estimation and Forecast by Country
9.4 LAMEA Market Size Estimation and Forecast by Type
9.5 LAMEA Market Size Estimation and Forecast by Phase
9.6 LAMEA Market Size Estimation and Forecast by End-User
9.7 LAMEA Market Size Estimation and Forecast by Functions
9.8 LAMEA Market Size Estimation and Forecast by Technique
9.9 Brazil Drug Discovery Informatics Market Analysis
9.10 South Africa Drug Discovery Informatics Market Analysis
9.11 Saudi Arabia Drug Discovery Informatics Market Analysis
9.12 Turkey Drug Discovery Informatics Market Analysis
9.13 UAE Drug Discovery Informatics Market Analysis
9.14 Rest of LAMEA Drug Discovery Informatics Market Analysis
9.15 Colombia
10 Leading Company Profiles
10.1 Growth Strategy Allows Companies to Expand Their Business
10.2 Jubilant Life Sciences
10.3 Charles River Laboratories International
10.4 International Business Machines Corporation
10.5 Clarivate Analytics
10.6 Accenture
10.7 Cognizant Technology Solutions Corporation
10.8 Thermo Fisher Scientific
10.9 Infosys Limited
10.10 GVK Biosciences
10.11 IO Informatics
10.12 OpenEye Scientific Software Inc.
10.13 Dassault Systèmes SE
10.14 Collaborative Drug Discovery
10.15 Schrödinger, Inc
10.16 PerkinElmer Inc
11 Conclusion and Recommendations
12 Glossary Terms
List of Tables
Table 1. Global Drug Discovery Informatics Market Snapshot, 2021 & 2031 (US$million, CAGR %)
Table 2. Drug Discovery Swot Analysis
Table 3. Global Drug Discovery Informatics Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 4. Global Drug Discovery Informatics Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 5. Global Drug Discovery Informatics Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 6. Global Drug Discovery Informatics Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 7. Global Drug Discovery Informatics Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 8. Global Drug Discovery Informatics Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 9. Global Drug Discovery Informatics Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 10. Global Drug Discovery Informatics Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 11. Global Drug Discovery Informatics Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 12. Global Drug Discovery Informatics Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L– Shaped Recovery)
Table 13. Global Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 14. Global Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 15. Global Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W– Shaped Recovery)
Table 16. Global Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 17. Global Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 18. Global Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 19. Global Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 20. Global Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 21. Global Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 22. Global Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L– Shaped Recovery)
Table 23. Global Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 24. Global Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 25. Global Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 26. Global Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 27. Global Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 28. Global Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 29. Global Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 30. Global Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W– Shaped Recovery)
Table 31. Global Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 32. Global Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 33. Global Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 34. Global Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 35. Global Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 36. Global Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 37. Global Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 38. North America Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 39. North America Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 40. North America Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 41. North America Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 42. North America Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 43. North America Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 44. North America Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 45. North America Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 46. North America Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 47. North America Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 48. North America Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 49. North America Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 50. North America Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 51. North America Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 52. North America Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 53. North America Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 54. North America Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 55. North America Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 56. North America Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 57. North America Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 58. North America Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 59. North America Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 60. North America Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 61. North America Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 62. North America Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 63. North America Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 64. North America Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 65. North America Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 66. North America Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 67. North America Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 68. North America Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 69. North America Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 70. North America Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 71. North America Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 72. North America Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 73. US Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 74. US Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 75. US Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 76. US Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 77. US Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 78. Canada Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 79. Canada Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 80. Canada Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 81. Mexico Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 82. Canada Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 83. Mexico Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 84. Mexico Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 85. Mexico Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 86. Mexico Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 87. Mexico Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 88. Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 89. Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 90. Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 91. Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 92. Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 93. Europe Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 94. Europe Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 95. Europe Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 96. Europe Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 97. Europe Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 98. Europe Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 99. Europe Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 100. Europe Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 101. Europe Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 102. Europe Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 103. Europe Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 104. Europe Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 105. Europe Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 106. Europe Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 107. Europe Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 108. Europe Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 109. Europe Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 110. Europe Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 111. Europe Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 112. Europe Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 113. Europe Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 114. Europe Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 115. Europe Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 116. Europe Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 117. Europe Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 118. Europe Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 119. Europe Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 120. Europe Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 121. Europe Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 122. Europe Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 123. Germany Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 124. Germany Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 125. Germany Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 126. Germany Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 127. Germany Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 128. UK Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 129. UK Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 130. UK Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 131. UK Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 132. UK Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 133. France Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 134. France Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 135. France Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 136. France Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 137. France Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 138. Italy Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 139. Italy Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 140. Italy Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 141. Italy Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 142. Italy Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 143. Spain Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 144. Spain Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 145. Spain Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 146. Spain Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 147. Spain Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 148. Rest of Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 149. Rest of Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 150. Rest of Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 151. Rest of Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 152. Rest of Europe Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 153. Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 154. Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 155. Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 156. Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 157. Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 158. Asia-Pacific Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 159. Asia-Pacific Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 160. Asia-Pacific Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 161. Asia-Pacific Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 162. Asia-Pacific Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 163. Asia-Pacific Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 164. Asia-Pacific Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 165. Asia-Pacific Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 166. Asia-Pacific Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 167. Asia-Pacific Drug Discovery Informatics Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 168. Asia-Pacific Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 169. Asia-Pacific Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 170. Asia-Pacific Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 171. Asia-Pacific Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 172. Asia-Pacific Drug Discovery Informatics Market by Phase, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 173. Asia-Pacific Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 174. Asia-Pacific Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 175. Asia-Pacific Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 176. Asia-Pacific Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 177. Asia-Pacific Drug Discovery Informatics Market by End-User, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 178. Asia-Pacific Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 179. Asia-Pacific Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 180. Asia-Pacific Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 181. Asia-Pacific Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 182. Asia-Pacific Drug Discovery Informatics Market by Function, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 183. Asia-Pacific Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 184. Asia-Pacific Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 185. Asia-Pacific Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 186. Asia-Pacific Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 187. Asia-Pacific Drug Discovery Informatics Market by Technique, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 188. China Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 189. China Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 190. China Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 191. China Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 192. China Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 193. India Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 194. India Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 195. India Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 196. India Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U– Shaped Recovery)
Table 197. India Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L– Shaped Recovery)
Table 198. Japan Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 199. Japan Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 200. Japan Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 201. Japan Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 202. Japan Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 203. South Korea Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 204. South Korea Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 205. South Korea Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 206. South Korea Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 207. South Korea Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 208. Australia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 209. Australia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 210. Australia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 211. Australia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 212. Australia Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 213. Rest of Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 214. Rest of Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 215. Rest of Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 216. Rest of Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 217. Rest of Asia-Pacific Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L – Shaped Recovery)
Table 218. LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 219. LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 220. LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 221. LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 222. LAMEA Drug Discovery Informatics Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))(L– Shaped Recovery)
Table 223. LAMEA Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Table 224. LAMEA Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(V – Shaped Recovery)
Table 225. LAMEA Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(W – Shaped Recovery)
Table 226. LAMEA Drug Discovery Informatics Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR (%))(U – Shaped Recovery)
Table 227. LAMEA Drug Discovery Informatics Market by Country, 2021-2031 (USD
